Detail Information of Xenobiotics
| General Information of Xenobiotics (ID: XEO01149) | ||||||
|---|---|---|---|---|---|---|
| Xenobiotics Name |
4-aminobenzhydrazide
|
|||||
| Xenobiotics Type |
Pharmaceutical Agent(s)
|
|||||
| Classification |
Investigative Agent
|
|||||
| Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=21450"></iframe>
|
 |
||||
| 3D MOL | 2D MOL | |||||
| PubChem CID | ||||||
| DME(s) Modulated by This Xenobiotics | ||||||
| DME(s) Inhibited by This Xenobiotics | ||||||
| Myeloperoxidase (MPO) | DME Info | Homo sapiens | [1] | |||
| Xenobiotics-DME Activity Data | ||||||
| Xenobiotics-DME Activity Data | Myeloperoxidase (MPO) | DME Info | IC50 = 0.3 microM | [1] | ||
| References | ||||||
| 1 | Evaluation of new scaffolds of myeloperoxidase inhibitors by rational design combined with high-throughput virtual screening. J Med Chem. 2012 Aug 23;55(16):7208-18. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.